Report Detail
Global (United States, European Union and China) Cimzia (certolizumab) Drug Market Research Report 2019-2025
- RnM3573825 |
- 19 July, 2019 |
- Global |
- 110 Pages |
- QYResearch |
- Other
Certolizumab pegol is a TNF (tumor necrosis factor) inhibitor that is primarily used to treat Crohns disease. Certolizumab pegol is a monoclonal antibody directed against tumor necrosis factor alpha (TNF-alfa). In 2008, it was approved for rheumatoid arthritis treatment under the brand CIMZIA®. It was used off-label to treat psoriatic arthritis until it was approved for this indication in 2013.
In 2019, the market size of Cimzia (certolizumab) Drug is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Cimzia (certolizumab) Drug.
This report studies the global market size of Cimzia (certolizumab) Drug, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Cimzia (certolizumab) Drug production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
UCB
...
Market Segment by Product Type
Crohn's Disease
Rheumatoid Arthritis
Market Segment by Application
Crohn's Disease
Rheumatoid Arthritis
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Cimzia (certolizumab) Drug status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Cimzia (certolizumab) Drug manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Cimzia (certolizumab) Drug are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Research Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Cimzia (certolizumab) Drug Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Crohn's Disease
- 1.3.3 Rheumatoid Arthritis
- 1.4 Market Segment by Application
- 1.4.1 Global Cimzia (certolizumab) Drug Market Share by Application (2019-2025)
- 1.4.2 Crohn's Disease
- 1.4.3 Rheumatoid Arthritis
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Production and Capacity Analysis
- 2.1.1 Global Cimzia (certolizumab) Drug Production Value 2014-2025
- 2.1.2 Global Cimzia (certolizumab) Drug Production 2014-2025
- 2.1.3 Global Cimzia (certolizumab) Drug Capacity 2014-2025
- 2.1.4 Global Cimzia (certolizumab) Drug Marketing Pricing and Trends
- 2.2 Key Producers Growth Rate (CAGR) 2019-2025
- 2.2.1 Global Cimzia (certolizumab) Drug Market Size CAGR of Key Regions
- 2.2.2 Global Cimzia (certolizumab) Drug Market Share of Key Regions
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Capacity and Production by Manufacturers
- 3.1.1 Global Cimzia (certolizumab) Drug Capacity by Manufacturers
- 3.1.2 Global Cimzia (certolizumab) Drug Production by Manufacturers
- 3.2 Revenue by Manufacturers
- 3.2.1 Cimzia (certolizumab) Drug Revenue by Manufacturers (2014-2019)
- 3.2.2 Cimzia (certolizumab) Drug Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Cimzia (certolizumab) Drug Market Concentration Ratio (CR5 and HHI)
- 3.3 Cimzia (certolizumab) Drug Price by Manufacturers
- 3.4 Key Manufacturers Cimzia (certolizumab) Drug Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Cimzia (certolizumab) Drug Market
- 3.6 Key Manufacturers Cimzia (certolizumab) Drug Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Production and Production Value for Each Type
- 4.1.1 Crohn's Disease Production and Production Value (2014-2019)
- 4.1.2 Rheumatoid Arthritis Production and Production Value (2014-2019)
- 4.2 Global Cimzia (certolizumab) Drug Production Market Share by Type
- 4.3 Global Cimzia (certolizumab) Drug Production Value Market Share by Type
- 4.4 Cimzia (certolizumab) Drug Ex-factory Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Cimzia (certolizumab) Drug Consumption by Application
6 Production by Regions
- 6.1 Global Cimzia (certolizumab) Drug Production (History Data) by Regions 2014-2019
- 6.2 Global Cimzia (certolizumab) Drug Production Value (History Data) by Regions
- 6.3 United States
- 6.3.1 United States Cimzia (certolizumab) Drug Production Growth Rate 2014-2019
- 6.3.2 United States Cimzia (certolizumab) Drug Production Value Growth Rate 2014-2019
- 6.3.3 Key Players in United States
- 6.3.4 United States Cimzia (certolizumab) Drug Import & Export
- 6.4 European Union
- 6.4.1 European Union Cimzia (certolizumab) Drug Production Growth Rate 2014-2019
- 6.4.2 European Union Cimzia (certolizumab) Drug Production Value Growth Rate 2014-2019
- 6.4.3 Key Players in European Union
- 6.4.4 European Union Cimzia (certolizumab) Drug Import & Export
- 6.5 China
- 6.5.1 China Cimzia (certolizumab) Drug Production Growth Rate 2014-2019
- 6.5.2 China Cimzia (certolizumab) Drug Production Value Growth Rate 2014-2019
- 6.5.3 Key Players in China
- 6.5.4 China Cimzia (certolizumab) Drug Import & Export
- 6.6 Rest of World
- 6.6.1 Japan
- 6.6.2 Korea
- 6.6.3 India
- 6.6.4 Southeast Asia
7 Cimzia (certolizumab) Drug Consumption by Regions
- 7.1 Global Cimzia (certolizumab) Drug Consumption (History Data) by Regions
- 7.2 United States
- 7.2.1 United States Cimzia (certolizumab) Drug Consumption by Type
- 7.2.2 United States Cimzia (certolizumab) Drug Consumption by Application
- 7.3 European Union
- 7.3.1 European Union Cimzia (certolizumab) Drug Consumption by Type
- 7.3.2 European Union Cimzia (certolizumab) Drug Consumption by Application
- 7.4 China
- 7.4.1 China Cimzia (certolizumab) Drug Consumption by Type
- 7.4.2 China Cimzia (certolizumab) Drug Consumption by Application
- 7.5 Rest of World
- 7.5.1 Rest of World Cimzia (certolizumab) Drug Consumption by Type
- 7.5.2 Rest of World Cimzia (certolizumab) Drug Consumption by Application
- 7.5.1 Japan
- 7.5.2 Korea
- 7.5.3 India
- 7.5.4 Southeast Asia
8 Company Profiles
- 8.1 UCB
- 8.1.1 UCB Company Details
- 8.1.2 Company Description and Business Overview
- 8.1.3 Production and Revenue of Cimzia (certolizumab) Drug
- 8.1.4 Cimzia (certolizumab) Drug Product Introduction
- 8.1.5 UCB Recent Development
9 Market Forecast
- 9.1 Global Market Size Forecast
- 9.1.1 Global Cimzia (certolizumab) Drug Capacity, Production Forecast 2019-2025
- 9.1.2 Global Cimzia (certolizumab) Drug Production Value Forecast 2019-2025
- 9.2 Market Forecast by Regions
- 9.2.1 Global Cimzia (certolizumab) Drug Production and Value Forecast by Regions 2019-2025
- 9.2.2 Global Cimzia (certolizumab) Drug Consumption Forecast by Regions 2019-2025
- 9.3 United States
- 9.3.1 Production and Value Forecast in United States
- 9.3.2 Consumption Forecast in United States
- 9.4 European Union
- 9.4.1 Production and Value Forecast in European Union
- 9.4.2 Consumption Forecast in European Union
- 9.5 China
- 9.5.1 Production and Value Forecast in China
- 9.5.2 Consumption Forecast in China
- 9.6 Rest of World
- 9.6.1 Japan
- 9.6.2 Korea
- 9.6.3 India
- 9.6.4 Southeast Asia
- 9.7 Forecast by Type
- 9.7.1 Global Cimzia (certolizumab) Drug Production Forecast by Type
- 9.7.2 Global Cimzia (certolizumab) Drug Production Value Forecast by Type
- 9.8 Consumption Forecast by Application
10 Value Chain and Sales Channels Analysis
- 10.1 Value Chain Analysis
- 10.2 Sales Channels Analysis
- 10.2.1 Cimzia (certolizumab) Drug Sales Channels
- 10.2.2 Cimzia (certolizumab) Drug Distributors
- 10.3 Cimzia (certolizumab) Drug Customers
11 Opportunities & Challenges, Threat and Affecting Factors
- 11.1 Market Opportunities
- 11.2 Market Challenges
- 11.3 Porter's Five Forces Analysis
12 Key Findings
13 Appendix
- 13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.1.1 Research Programs/Design
- 13.1.1.2 Market Size Estimation
- 13.1.1.3 Market Breakdown and Data Triangulation
- 13.1.2 Data Source
- 13.1.2.1 Secondary Sources
- 13.1.2.2 Primary Sources
- 13.1.1 Methodology/Research Approach
- 13.2 Author Details
Summary:
Get latest Market Research Reports on Cimzia (certolizumab) Drug . Industry analysis & Market Report on Cimzia (certolizumab) Drug is a syndicated market report, published as Global (United States, European Union and China) Cimzia (certolizumab) Drug Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Cimzia (certolizumab) Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
